Skip to content
JWH-018
EntityQ419020· pop 14· linked from 983 articles

JWH-018 (1-pentyl-3-(1-naphthoyl)indole, NA-PIMO or AM-678) is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with some selectivity for CB2. It produces effects in animals similar to those of tetrahydrocannabinol (THC), a cannabinoid naturally present in cannabis, leading to its use as synthetic cannabinoid products that, in some countries, are sold legally as "incense blends".

Key facts

Drug.O
1
Drug.H
23
Drug.N
1
Drug.Verifiedfields
changed
Drug.class
Cannabinoid
Drug.verifiedrevid
477168756
Drug.IUPAC_name
(Naphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone
Drug.image
JWH018.svg
Drug.image_class
skin-invert-image
Drug.image2
JWH-018 ball-and-stick model.png
Drug.image_class2
bg-transparent
Drug.legal_AU
S9
Drug.legal_BR
F2
Drug.legal_UK
Class B
Drug.legal_US
Schedule I
Drug.legal_DE
Anlage II
Drug.legal_CA
Schedule II, In general uncontrolled could be illegal to sell for human consumption or the analogue acts in several countries.
Drug.legal_UN
P II

via Wikipedia infobox

~10 min read

Encyclopedic overview

11 sections
Contents
  • History
  • Pharmacology
  • Pharmacokinetics
  • Recreational use
  • Detection in biological fluids
  • Legal status
  • Synthesis
  • See also
  • References
  • Further reading
  • External links

JWH-018 (1-pentyl-3-(1-naphthoyl)indole, NA-PIMO or AM-678) is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with some selectivity for CB2. It produces effects in animals similar to those of tetrahydrocannabinol (THC), a cannabinoid naturally present in cannabis, leading to its use as synthetic cannabinoid products that, in some countries, are sold legally as "incense blends".

As a full agonist at both the CB1 and CB2 cannabinoid receptors, this chemical compound is classified as an analgesic medication. The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well established in treatment of neuropathic pain, as well as cancer pain and arthritis.

Excerpted from Wikipedia’s “JWH-018” article, available under the CC BY-SA 4.0 licence.

Gallery (2)